Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 50.7× earnings vs its 23.8× historical median P/E.
Fair value ≈ $4.23 · price $9.00 today
Overvalued · 113% above
Loading valuation…
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$AXL Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.52 down -966.67% YoY
• Reported revenue of $2.38B up 68.56% YoY
• Dauch updated its full year 2026 financial targets, expecting sales between $10.3B and $10.8B, and Adjusted EBITDA from $1.3B to $1.43B, including $50M in synergy benefits.
$AXL absolutely infuriating for shareholders -20%!!. I feel bad for shareholders. Glad i did my usual sell ahead of the ER. I'm adding shares today, to keep it on my screens. Will wait till chart bases out and revisit.
$AXL Are analysts just stupid or are they lying agents for the investment bankers bringing in the M&A fees?
Merger hopes and dreams meets realilty of making it all work in one chart:
$AXL Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of -$0.63 down -425.00% YoY
• Reported revenue of $1.38B up 0.22% YoY
• Dauch targets full year 2026 sales between $10.3B and $10.7B, Adjusted EBITDA from $1.3B to $1.4B, and Adjusted free cash flow from $235M to $325M, including Dowlais's partial year contribution.
$AXL 1W CCI shows bottoming signs while 1D STOCH indicates a momentum shift. 4H RSI remains range-bound, yet 30M liquidity flows suggest a breakout is imminent if volume confirms the move. @DailyAnalysis
$ALGN $AXL $DNA $ULCC $UVXY this prediction did not go well for this idiot, uvxy still down! 😂 stop posting videos that u know nothing about , everybody nowadays think they are gurus and have answers to everything 🤦🏻♂️ dummy
